

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.66755798 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.60186095 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.60186095 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.38303305 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.38303305 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.01203779 |
| 7 | high-density lipoprotein particle remodeling (GO:0034375) | 5.57127441 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 5.53385944 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.52678347 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.52678347 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.52678347 |
| 12 | urea cycle (GO:0000050) | 5.49091718 |
| 13 | urea metabolic process (GO:0019627) | 5.49091718 |
| 14 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.39482758 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.35190646 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.32541549 |
| 17 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.29784568 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.19194195 |
| 19 | phospholipid efflux (GO:0033700) | 5.13654162 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.11977077 |
| 21 | reverse cholesterol transport (GO:0043691) | 5.05302959 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.04138791 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.01469751 |
| 24 | cysteine metabolic process (GO:0006534) | 4.97287074 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.97226627 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.93321304 |
| 27 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91628476 |
| 28 | protein-lipid complex remodeling (GO:0034368) | 4.91628476 |
| 29 | macromolecular complex remodeling (GO:0034367) | 4.91628476 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.88024251 |
| 31 | protein carboxylation (GO:0018214) | 4.86730031 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.86730031 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.85958369 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.77693289 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.77693289 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71612057 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.69034444 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.65003273 |
| 39 | bile acid metabolic process (GO:0008206) | 4.62706432 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.61504477 |
| 41 | cholesterol efflux (GO:0033344) | 4.53888627 |
| 42 | cilium movement (GO:0003341) | 4.46964437 |
| 43 | intestinal cholesterol absorption (GO:0030299) | 4.46437162 |
| 44 | plasma lipoprotein particle assembly (GO:0034377) | 4.45881367 |
| 45 | axonemal dynein complex assembly (GO:0070286) | 4.45235844 |
| 46 | epithelial cilium movement (GO:0003351) | 4.45045930 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.41271393 |
| 48 | regulation of complement activation (GO:0030449) | 4.40824918 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.35789689 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.35737129 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 4.34986929 |
| 52 | lysine catabolic process (GO:0006554) | 4.32771951 |
| 53 | lysine metabolic process (GO:0006553) | 4.32771951 |
| 54 | drug catabolic process (GO:0042737) | 4.27944239 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.25616926 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.25529683 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.25529683 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.19328647 |
| 59 | ketone body metabolic process (GO:1902224) | 4.17178134 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.14304272 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.10014235 |
| 62 | protein-lipid complex assembly (GO:0065005) | 4.09933730 |
| 63 | cellular glucuronidation (GO:0052695) | 4.09072818 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.08506950 |
| 65 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.02984978 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.02984978 |
| 67 | amine catabolic process (GO:0009310) | 3.97635653 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 3.97635653 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.92014848 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.90714513 |
| 71 | cholesterol homeostasis (GO:0042632) | 3.90035013 |
| 72 | plasma lipoprotein particle organization (GO:0071827) | 3.89523931 |
| 73 | glutamate metabolic process (GO:0006536) | 3.87808727 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.87504574 |
| 75 | indolalkylamine metabolic process (GO:0006586) | 3.85619429 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.85332944 |
| 77 | piRNA metabolic process (GO:0034587) | 3.85046797 |
| 78 | sterol homeostasis (GO:0055092) | 3.83919551 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 3.79545631 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79011020 |
| 81 | lipoprotein metabolic process (GO:0042157) | 3.76671855 |
| 82 | axoneme assembly (GO:0035082) | 3.74394982 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.72894719 |
| 84 | protein-lipid complex subunit organization (GO:0071825) | 3.72287073 |
| 85 | regulation of relaxation of muscle (GO:1901077) | 3.72212104 |
| 86 | arginine metabolic process (GO:0006525) | 3.71141220 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.70818184 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.70738144 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70619853 |
| 90 | intestinal absorption (GO:0050892) | 3.68955222 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.68046220 |
| 92 | ethanol oxidation (GO:0006069) | 3.66589728 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.65784790 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.65784790 |
| 95 | complement activation (GO:0006956) | 3.65232657 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.61618104 |
| 97 | glycine metabolic process (GO:0006544) | 3.61459517 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.59235280 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.58876934 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.53930680 |
| 101 | cofactor catabolic process (GO:0051187) | 3.52098830 |
| 102 | protein activation cascade (GO:0072376) | 3.51118779 |
| 103 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.50254061 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.49959712 |
| 105 | regulation of cholesterol homeostasis (GO:2000188) | 3.49274508 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.49102792 |
| 107 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48167027 |
| 108 | amino acid salvage (GO:0043102) | 3.47757230 |
| 109 | L-methionine salvage (GO:0071267) | 3.47757230 |
| 110 | L-methionine biosynthetic process (GO:0071265) | 3.47757230 |
| 111 | aldehyde catabolic process (GO:0046185) | 3.47033186 |
| 112 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.46885914 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.44941432 |
| 114 | fibrinolysis (GO:0042730) | 3.42323350 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.38940969 |
| 116 | organic acid catabolic process (GO:0016054) | 3.37913530 |
| 117 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.37785635 |
| 118 | regulation of cilium movement (GO:0003352) | 3.37229887 |
| 119 | behavioral response to nicotine (GO:0035095) | 3.36346378 |
| 120 | oxidative demethylation (GO:0070989) | 3.35737231 |
| 121 | dopamine transport (GO:0015872) | 3.30567699 |
| 122 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20038778 |
| 123 | regulation of actin filament-based movement (GO:1903115) | 3.16061461 |
| 124 | fatty acid transmembrane transport (GO:1902001) | 3.13906742 |
| 125 | regulation of cell communication by electrical coupling (GO:0010649) | 3.12343726 |
| 126 | regulation of glucokinase activity (GO:0033131) | 3.07426586 |
| 127 | regulation of hexokinase activity (GO:1903299) | 3.07426586 |
| 128 | phenol-containing compound catabolic process (GO:0019336) | 3.06062832 |
| 129 | epoxygenase P450 pathway (GO:0019373) | 3.03701739 |
| 130 | DNA methylation involved in gamete generation (GO:0043046) | 3.03628998 |
| 131 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.03348355 |
| 132 | photoreceptor cell maintenance (GO:0045494) | 3.01473243 |
| 133 | behavioral response to ethanol (GO:0048149) | 2.95555008 |
| 134 | auditory receptor cell stereocilium organization (GO:0060088) | 2.94444205 |
| 135 | sarcomere organization (GO:0045214) | 2.94076702 |
| 136 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.93796564 |
| 137 | thyroid hormone metabolic process (GO:0042403) | 2.92034001 |
| 138 | S-adenosylmethionine metabolic process (GO:0046500) | 2.87187292 |
| 139 | myofibril assembly (GO:0030239) | 2.85261710 |
| 140 | motile cilium assembly (GO:0044458) | 2.83559698 |
| 141 | methionine biosynthetic process (GO:0009086) | 2.79910695 |
| 142 | platelet dense granule organization (GO:0060155) | 2.77490127 |
| 143 | thyroid hormone generation (GO:0006590) | 2.77039177 |
| 144 | muscle filament sliding (GO:0030049) | 2.73135865 |
| 145 | actin-myosin filament sliding (GO:0033275) | 2.73135865 |
| 146 | regulation of action potential (GO:0098900) | 2.70739732 |
| 147 | cardiac myofibril assembly (GO:0055003) | 2.69958514 |
| 148 | regulation of sarcomere organization (GO:0060297) | 2.69618347 |
| 149 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66080786 |
| 150 | cilium morphogenesis (GO:0060271) | 2.64832641 |
| 151 | cilium organization (GO:0044782) | 2.61321883 |
| 152 | omega-hydroxylase P450 pathway (GO:0097267) | 2.60492899 |
| 153 | aspartate family amino acid catabolic process (GO:0009068) | 2.59255213 |
| 154 | gamma-aminobutyric acid transport (GO:0015812) | 2.58716698 |
| 155 | membrane depolarization during action potential (GO:0086010) | 2.58131163 |
| 156 | cardiac muscle contraction (GO:0060048) | 2.57802485 |
| 157 | regulation of membrane repolarization (GO:0060306) | 2.57028250 |
| 158 | response to pheromone (GO:0019236) | 2.56646805 |
| 159 | cilium assembly (GO:0042384) | 2.54997159 |
| 160 | actin-mediated cell contraction (GO:0070252) | 2.53679772 |
| 161 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.53292146 |
| 162 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.51672953 |
| 163 | carnitine shuttle (GO:0006853) | 2.51419946 |
| 164 | male meiosis (GO:0007140) | 2.51210830 |
| 165 | somite development (GO:0061053) | 2.50989026 |
| 166 | quaternary ammonium group transport (GO:0015697) | 2.50896024 |
| 167 | synapsis (GO:0007129) | 2.50585323 |
| 168 | indole-containing compound metabolic process (GO:0042430) | 2.49342390 |
| 169 | neuronal action potential propagation (GO:0019227) | 2.48341721 |
| 170 | cardiac muscle hypertrophy (GO:0003300) | 2.48156614 |
| 171 | positive regulation of heart rate (GO:0010460) | 2.47638332 |
| 172 | nonmotile primary cilium assembly (GO:0035058) | 2.47368205 |
| 173 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.47316956 |
| 174 | synaptic transmission, cholinergic (GO:0007271) | 2.46552214 |
| 175 | ubiquinone biosynthetic process (GO:0006744) | 2.46496827 |
| 176 | carnitine transmembrane transport (GO:1902603) | 2.46403569 |
| 177 | detection of light stimulus involved in visual perception (GO:0050908) | 2.45964522 |
| 178 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.45964522 |
| 179 | carnitine transport (GO:0015879) | 2.44296937 |
| 180 | amino-acid betaine transport (GO:0015838) | 2.44296937 |
| 181 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.44003546 |
| 182 | drug metabolic process (GO:0017144) | 2.43521997 |
| 183 | regulation of skeletal muscle contraction (GO:0014819) | 2.43418647 |
| 184 | regulation of microtubule-based movement (GO:0060632) | 2.42997445 |
| 185 | neuronal action potential (GO:0019228) | 2.41728543 |
| 186 | C4-dicarboxylate transport (GO:0015740) | 2.41334312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.53543890 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.55619826 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.35259240 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98704950 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.68121785 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.39146581 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.15277878 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.07360722 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.58039092 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.41621960 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.29577340 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00083886 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84375958 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.61379090 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.49832389 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42216924 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33541145 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29210093 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27677860 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11007155 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.06646667 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06421464 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04003941 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5177479 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94324171 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.91081981 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89491670 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.89361654 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86813526 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86685866 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.86632042 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83346019 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81229628 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81151841 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.78176817 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73458436 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73204966 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72020338 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69260469 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66590889 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.66477677 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.65162854 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62446708 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59474216 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55054577 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54679298 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.54621145 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54166538 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.53824787 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53673034 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52756546 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49798752 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49774697 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48106409 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44710508 |
| 56 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43930846 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43474683 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41731479 |
| 59 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40466838 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39973994 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39591776 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38042810 |
| 63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37694779 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37651157 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34713414 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33645545 |
| 67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33597542 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33597542 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32403727 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32403727 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31775002 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30081942 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29741039 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29629818 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29501263 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29395819 |
| 77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28956611 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28664411 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28465759 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28224602 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26616106 |
| 82 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26608027 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25282141 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19180178 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18445367 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18238521 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18215851 |
| 88 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18120832 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16807545 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15819435 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15376849 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14514139 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14017190 |
| 94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13680613 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13501817 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13409385 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13366017 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13366017 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13173016 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12963416 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11977852 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11285721 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10522962 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10496995 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09917036 |
| 106 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09589404 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07730059 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07656217 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07362744 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06898439 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06032722 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05981831 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05942465 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05896315 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05636541 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05041124 |
| 117 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04341757 |
| 118 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04074885 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02190845 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01483361 |
| 121 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01348605 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01344763 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00751026 |
| 124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00181385 |
| 125 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99751556 |
| 126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99279982 |
| 127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98565273 |
| 128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98303303 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98299606 |
| 130 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98181947 |
| 131 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98181947 |
| 132 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98087802 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95621280 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89356454 |
| 135 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88616475 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87642903 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86982727 |
| 138 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84317363 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84224258 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82345554 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81182249 |
| 142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77465943 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76532655 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.74054609 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73102137 |
| 146 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72900858 |
| 147 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71141601 |
| 148 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69723560 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69156890 |
| 150 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67742898 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67004329 |
| 152 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66619748 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66031916 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66031916 |
| 155 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65858173 |
| 156 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65626493 |
| 157 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64288723 |
| 158 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63236532 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61758391 |
| 160 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61107881 |
| 161 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.61049328 |
| 162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60330220 |
| 163 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.59790371 |
| 164 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.58309928 |
| 165 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58031211 |
| 166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57933235 |
| 167 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57282496 |
| 168 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.57245061 |
| 169 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56549704 |
| 170 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.56284224 |
| 171 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.55529107 |
| 172 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.54965669 |
| 173 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.54894440 |
| 174 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54614070 |
| 175 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54610523 |
| 176 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.53207213 |
| 177 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53187228 |
| 178 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52767642 |
| 179 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52242358 |
| 180 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52218255 |
| 181 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.52009277 |
| 182 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51839400 |
| 183 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.51310501 |
| 184 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51079696 |
| 185 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.51045847 |
| 186 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50325359 |
| 187 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49978424 |
| 188 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49939024 |
| 189 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48695058 |
| 190 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.48510669 |
| 191 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48071502 |
| 192 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.47428097 |
| 193 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.46790330 |
| 194 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.46575029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.85035330 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.63248493 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.98091131 |
| 4 | MP0005365_abnormal_bile_salt | 5.44813078 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69576690 |
| 6 | MP0003252_abnormal_bile_duct | 4.04810219 |
| 7 | MP0003646_muscle_fatigue | 3.90151071 |
| 8 | MP0009840_abnormal_foam_cell | 3.89420326 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.47900450 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.47385425 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.42912772 |
| 12 | MP0004215_abnormal_myocardial_fiber | 3.08818141 |
| 13 | MP0001666_abnormal_nutrient_absorption | 3.07163642 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.86618044 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.83845500 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.68518135 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.67134892 |
| 18 | MP0005332_abnormal_amino_acid | 2.66788893 |
| 19 | MP0005083_abnormal_biliary_tract | 2.30680223 |
| 20 | MP0001984_abnormal_olfaction | 2.29713070 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.22661390 |
| 22 | MP0003195_calcinosis | 2.14404051 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.10486876 |
| 24 | MP0000609_abnormal_liver_physiology | 2.08751945 |
| 25 | MP0004036_abnormal_muscle_relaxation | 2.08301967 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.99162829 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.98292251 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.92388614 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.91961320 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.87746767 |
| 31 | MP0002102_abnormal_ear_morphology | 1.85534344 |
| 32 | MP0004484_altered_response_of | 1.84585994 |
| 33 | MP0000751_myopathy | 1.78083420 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.74711882 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.70073622 |
| 36 | MP0009745_abnormal_behavioral_response | 1.68306083 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.64521691 |
| 38 | MP0004043_abnormal_pH_regulation | 1.60119593 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.59556785 |
| 40 | MP0009697_abnormal_copulation | 1.55808192 |
| 41 | MP0001486_abnormal_startle_reflex | 1.55583705 |
| 42 | MP0000383_abnormal_hair_follicle | 1.55561105 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55040579 |
| 44 | MP0004085_abnormal_heartbeat | 1.54894227 |
| 45 | MP0009046_muscle_twitch | 1.54321653 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.51621694 |
| 47 | MP0003868_abnormal_feces_composition | 1.50064385 |
| 48 | MP0005330_cardiomyopathy | 1.47234210 |
| 49 | MP0002272_abnormal_nervous_system | 1.47055088 |
| 50 | MP0002736_abnormal_nociception_after | 1.46405946 |
| 51 | MP0000749_muscle_degeneration | 1.45156799 |
| 52 | MP0000427_abnormal_hair_cycle | 1.41093484 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.38715471 |
| 54 | * MP0001764_abnormal_homeostasis | 1.37866566 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.37717392 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.36431816 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.35347588 |
| 58 | MP0002972_abnormal_cardiac_muscle | 1.33350598 |
| 59 | MP0003880_abnormal_central_pattern | 1.30980695 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.30464397 |
| 61 | MP0004133_heterotaxia | 1.29518672 |
| 62 | MP0004142_abnormal_muscle_tone | 1.28850117 |
| 63 | MP0005253_abnormal_eye_physiology | 1.28343151 |
| 64 | MP0005451_abnormal_body_composition | 1.25218591 |
| 65 | MP0000604_amyloidosis | 1.21866211 |
| 66 | MP0009764_decreased_sensitivity_to | 1.18143881 |
| 67 | MP0004885_abnormal_endolymph | 1.16763093 |
| 68 | MP0008469_abnormal_protein_level | 1.16423568 |
| 69 | MP0002653_abnormal_ependyma_morphology | 1.16393728 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.15996265 |
| 71 | MP0002106_abnormal_muscle_physiology | 1.15725850 |
| 72 | MP0003436_decreased_susceptibility_to | 1.15401707 |
| 73 | MP0003690_abnormal_glial_cell | 1.14763345 |
| 74 | MP0003011_delayed_dark_adaptation | 1.14569253 |
| 75 | MP0002254_reproductive_system_inflammat | 1.10778867 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.10666355 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.09165228 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.08680630 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.08588819 |
| 80 | * MP0000598_abnormal_liver_morphology | 1.08327525 |
| 81 | MP0002064_seizures | 1.08217744 |
| 82 | MP0001485_abnormal_pinna_reflex | 1.06983848 |
| 83 | MP0003186_abnormal_redox_activity | 1.06944387 |
| 84 | MP0006082_CNS_inflammation | 1.05317447 |
| 85 | MP0009763_increased_sensitivity_to | 1.04785652 |
| 86 | MP0002127_abnormal_cardiovascular_syste | 1.04544014 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 1.04411940 |
| 88 | MP0001661_extended_life_span | 1.04333283 |
| 89 | MP0003075_altered_response_to | 1.04167495 |
| 90 | MP0002735_abnormal_chemical_nociception | 1.03261727 |
| 91 | MP0005385_cardiovascular_system_phenoty | 1.01396338 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 1.01396338 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.99937353 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.96255902 |
| 95 | MP0005647_abnormal_sex_gland | 0.96214124 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.95866905 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.95343674 |
| 98 | * MP0009642_abnormal_blood_homeostasis | 0.94743360 |
| 99 | MP0002160_abnormal_reproductive_system | 0.94662199 |
| 100 | MP0005369_muscle_phenotype | 0.94484145 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.92942132 |
| 102 | MP0003136_yellow_coat_color | 0.92907238 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.92573768 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.92268063 |
| 105 | MP0004924_abnormal_behavior | 0.92268063 |
| 106 | MP0003635_abnormal_synaptic_transmissio | 0.92256246 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.91229164 |
| 108 | MP0002063_abnormal_learning/memory/cond | 0.89164291 |
| 109 | MP0001970_abnormal_pain_threshold | 0.88466136 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.88423272 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.87110605 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.85886601 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.84824133 |
| 114 | MP0004147_increased_porphyrin_level | 0.83490533 |
| 115 | MP0005670_abnormal_white_adipose | 0.83449982 |
| 116 | MP0005166_decreased_susceptibility_to | 0.82954595 |
| 117 | MP0003724_increased_susceptibility_to | 0.82768897 |
| 118 | MP0006138_congestive_heart_failure | 0.82582662 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.80999385 |
| 120 | MP0005408_hypopigmentation | 0.80670064 |
| 121 | MP0002419_abnormal_innate_immunity | 0.78918154 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.78710949 |
| 123 | MP0000631_abnormal_neuroendocrine_gland | 0.78507250 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.78291906 |
| 125 | MP0003698_abnormal_male_reproductive | 0.77931964 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.77665002 |
| 127 | MP0002269_muscular_atrophy | 0.76864117 |
| 128 | MP0003787_abnormal_imprinting | 0.76116192 |
| 129 | MP0002229_neurodegeneration | 0.76073268 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.75657685 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.75409211 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.74545002 |
| 133 | MP0002132_abnormal_respiratory_system | 0.73059850 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.72483634 |
| 135 | * MP0005376_homeostasis/metabolism_phenot | 0.72292723 |
| 136 | MP0005334_abnormal_fat_pad | 0.69868469 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.69510574 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.68310422 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.66958936 |
| 140 | MP0002971_abnormal_brown_adipose | 0.66708869 |
| 141 | MP0002928_abnormal_bile_duct | 0.65510783 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.65479706 |
| 143 | MP0005535_abnormal_body_temperature | 0.65300124 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.64862307 |
| 145 | MP0001756_abnormal_urination | 0.64689883 |
| 146 | MP0001853_heart_inflammation | 0.62658863 |
| 147 | MP0005448_abnormal_energy_balance | 0.61238903 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.61044891 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.60593599 |
| 150 | MP0005025_abnormal_response_to | 0.60103407 |
| 151 | MP0008873_increased_physiological_sensi | 0.59646940 |
| 152 | MP0009785_altered_susceptibility_to | 0.58790734 |
| 153 | MP0003329_amyloid_beta_deposits | 0.58068202 |
| 154 | MP0004130_abnormal_muscle_cell | 0.55046749 |
| 155 | MP0004883_abnormal_blood_vessel | 0.54597403 |
| 156 | MP0004947_skin_inflammation | 0.53384757 |
| 157 | MP0001533_abnormal_skeleton_physiology | 0.52994832 |
| 158 | MP0000249_abnormal_blood_vessel | 0.52882795 |
| 159 | MP0010234_abnormal_vibrissa_follicle | 0.52797607 |
| 160 | MP0010155_abnormal_intestine_physiology | 0.51507512 |
| 161 | MP0009053_abnormal_anal_canal | 0.51355725 |
| 162 | MP0005266_abnormal_metabolism | 0.49814040 |
| 163 | MP0006036_abnormal_mitochondrial_physio | 0.49136310 |
| 164 | MP0004782_abnormal_surfactant_physiolog | 0.48634764 |
| 165 | MP0003172_abnormal_lysosome_physiology | 0.47554970 |
| 166 | MP0002822_catalepsy | 0.47544016 |
| 167 | MP0009115_abnormal_fat_cell | 0.46352628 |
| 168 | MP0002090_abnormal_vision | 0.45509816 |
| 169 | MP0008874_decreased_physiological_sensi | 0.45216288 |
| 170 | MP0000639_abnormal_adrenal_gland | 0.45082670 |
| 171 | MP0002148_abnormal_hypersensitivity_rea | 0.44460810 |
| 172 | MP0005164_abnormal_response_to | 0.42228123 |
| 173 | MP0004264_abnormal_extraembryonic_tissu | 0.41750639 |
| 174 | MP0005395_other_phenotype | 0.41080554 |
| 175 | MP0005220_abnormal_exocrine_pancreas | 0.39932581 |
| 176 | MP0001800_abnormal_humoral_immune | 0.39741298 |
| 177 | MP0008872_abnormal_physiological_respon | 0.39369274 |
| 178 | MP0003718_maternal_effect | 0.38393866 |
| 179 | MP0003953_abnormal_hormone_level | 0.38100737 |
| 180 | MP0005666_abnormal_adipose_tissue | 0.37893918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.59749183 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.46372511 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.45697521 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.23044623 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.18667574 |
| 6 | Xanthomatosis (HP:0000991) | 5.95147301 |
| 7 | Complement deficiency (HP:0004431) | 5.94080211 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.56643687 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.80099656 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.71487094 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.68088866 |
| 12 | Joint hemorrhage (HP:0005261) | 4.55355940 |
| 13 | Abnormality of complement system (HP:0005339) | 4.52241557 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.48394896 |
| 15 | Pancreatic cysts (HP:0001737) | 4.34912485 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 4.24196228 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.24196228 |
| 18 | Hyperammonemia (HP:0001987) | 4.22734301 |
| 19 | Epidermoid cyst (HP:0200040) | 4.14893911 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.12389875 |
| 21 | Pancreatic fibrosis (HP:0100732) | 4.12286412 |
| 22 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.07453035 |
| 23 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.07453035 |
| 24 | Fat malabsorption (HP:0002630) | 4.06496686 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.05381826 |
| 26 | Glomerulonephritis (HP:0000099) | 4.04283594 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.04194580 |
| 28 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.99181096 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96912893 |
| 30 | Hyperglycinuria (HP:0003108) | 3.90543026 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.90275465 |
| 32 | Abnormal ciliary motility (HP:0012262) | 3.85283403 |
| 33 | Hyperglycinemia (HP:0002154) | 3.82175037 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.77338580 |
| 35 | True hermaphroditism (HP:0010459) | 3.76270342 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71266985 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.71266985 |
| 38 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.70792181 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 3.69331607 |
| 40 | Ketosis (HP:0001946) | 3.68549787 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67602420 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 3.64752072 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.61859337 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.55845538 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 3.55845538 |
| 46 | Nephronophthisis (HP:0000090) | 3.41918920 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 3.37872898 |
| 48 | Hypoglycemic coma (HP:0001325) | 3.30676078 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23824351 |
| 50 | Bundle branch block (HP:0011710) | 3.21615577 |
| 51 | Type II lissencephaly (HP:0007260) | 3.19014335 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 3.16411146 |
| 53 | Hyperbilirubinemia (HP:0002904) | 3.13327891 |
| 54 | Rhinitis (HP:0012384) | 3.11170550 |
| 55 | Sudden death (HP:0001699) | 3.10481572 |
| 56 | Atrial fibrillation (HP:0005110) | 3.08659709 |
| 57 | Cystic liver disease (HP:0006706) | 3.07166269 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04067833 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03561031 |
| 60 | Bile duct proliferation (HP:0001408) | 3.03099308 |
| 61 | Abnormal biliary tract physiology (HP:0012439) | 3.03099308 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01310048 |
| 63 | Calf muscle hypertrophy (HP:0008981) | 2.99560251 |
| 64 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.99399710 |
| 65 | Acanthocytosis (HP:0001927) | 2.97911780 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95765330 |
| 67 | Syncope (HP:0001279) | 2.95416137 |
| 68 | Myocardial infarction (HP:0001658) | 2.95402458 |
| 69 | Gait imbalance (HP:0002141) | 2.94473770 |
| 70 | Primary atrial arrhythmia (HP:0001692) | 2.86268940 |
| 71 | Chronic hepatic failure (HP:0100626) | 2.84717785 |
| 72 | Decreased circulating renin level (HP:0003351) | 2.83709081 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.82908026 |
| 74 | Left ventricular hypertrophy (HP:0001712) | 2.82729629 |
| 75 | Ketoacidosis (HP:0001993) | 2.79555364 |
| 76 | Tubular atrophy (HP:0000092) | 2.78812207 |
| 77 | Amyloidosis (HP:0011034) | 2.78790931 |
| 78 | Skin nodule (HP:0200036) | 2.77005443 |
| 79 | Steatorrhea (HP:0002570) | 2.75112792 |
| 80 | Abnormal drinking behavior (HP:0030082) | 2.72959699 |
| 81 | Polydipsia (HP:0001959) | 2.72959699 |
| 82 | Renal cortical cysts (HP:0000803) | 2.72882599 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.72300540 |
| 84 | Malnutrition (HP:0004395) | 2.71455671 |
| 85 | Vascular calcification (HP:0004934) | 2.68368797 |
| 86 | Delayed CNS myelination (HP:0002188) | 2.67036129 |
| 87 | Supraventricular tachycardia (HP:0004755) | 2.66502993 |
| 88 | Hyperventilation (HP:0002883) | 2.66297214 |
| 89 | Metabolic acidosis (HP:0001942) | 2.63646245 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.62634558 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.62634558 |
| 92 | Abnormality of the calf musculature (HP:0001430) | 2.61960905 |
| 93 | Nephritis (HP:0000123) | 2.61373578 |
| 94 | Febrile seizures (HP:0002373) | 2.60978971 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59738586 |
| 96 | Abnormality of alanine metabolism (HP:0010916) | 2.59738586 |
| 97 | Hyperalaninemia (HP:0003348) | 2.59738586 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.59346527 |
| 99 | Nephrogenic diabetes insipidus (HP:0009806) | 2.59320453 |
| 100 | Congenital stationary night blindness (HP:0007642) | 2.57047796 |
| 101 | Supraventricular arrhythmia (HP:0005115) | 2.55001195 |
| 102 | Hepatocellular carcinoma (HP:0001402) | 2.49328062 |
| 103 | Mitral stenosis (HP:0001718) | 2.47740959 |
| 104 | Heart block (HP:0012722) | 2.45438046 |
| 105 | Occipital encephalocele (HP:0002085) | 2.44510682 |
| 106 | Spontaneous abortion (HP:0005268) | 2.42225109 |
| 107 | Sensorimotor neuropathy (HP:0007141) | 2.41473856 |
| 108 | Congenital hepatic fibrosis (HP:0002612) | 2.40512535 |
| 109 | Cardiovascular calcification (HP:0011915) | 2.35133467 |
| 110 | Hypochromic microcytic anemia (HP:0004840) | 2.33795438 |
| 111 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32590218 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 2.32590218 |
| 113 | Gingival bleeding (HP:0000225) | 2.32286890 |
| 114 | Irritability (HP:0000737) | 2.28976636 |
| 115 | Genital tract atresia (HP:0001827) | 2.28281681 |
| 116 | Menorrhagia (HP:0000132) | 2.24010329 |
| 117 | Vaginal atresia (HP:0000148) | 2.23177083 |
| 118 | Lethargy (HP:0001254) | 2.23143446 |
| 119 | Hypoglycemic seizures (HP:0002173) | 2.20475726 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 2.16069969 |
| 121 | Cholecystitis (HP:0001082) | 2.16069969 |
| 122 | Gout (HP:0001997) | 2.15347077 |
| 123 | Poikilocytosis (HP:0004447) | 2.14588731 |
| 124 | Late onset (HP:0003584) | 2.14577607 |
| 125 | Poor coordination (HP:0002370) | 2.13403843 |
| 126 | Pancreatitis (HP:0001733) | 2.13313289 |
| 127 | Bronchiectasis (HP:0002110) | 2.12732926 |
| 128 | Abnormal gallbladder morphology (HP:0012437) | 2.12179701 |
| 129 | Chronic bronchitis (HP:0004469) | 2.11685665 |
| 130 | Spastic diplegia (HP:0001264) | 2.07967858 |
| 131 | Cerebellar dysplasia (HP:0007033) | 2.07946943 |
| 132 | Esophageal varix (HP:0002040) | 2.07602350 |
| 133 | Cholelithiasis (HP:0001081) | 2.05336435 |
| 134 | Sclerocornea (HP:0000647) | 2.04474650 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.04407695 |
| 136 | Abnormal atrioventricular conduction (HP:0005150) | 2.01622507 |
| 137 | Progressive cerebellar ataxia (HP:0002073) | 1.99970190 |
| 138 | Abolished electroretinogram (ERG) (HP:0000550) | 1.98999183 |
| 139 | Muscle fiber splitting (HP:0003555) | 1.98310981 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.98082643 |
| 141 | Tubulointerstitial nephritis (HP:0001970) | 1.97065809 |
| 142 | Opisthotonus (HP:0002179) | 1.96989631 |
| 143 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.96749485 |
| 144 | Furrowed tongue (HP:0000221) | 1.94784595 |
| 145 | Polyuria (HP:0000103) | 1.94443694 |
| 146 | Asplenia (HP:0001746) | 1.94029493 |
| 147 | Atonic seizures (HP:0010819) | 1.93635541 |
| 148 | Abnormality of vitamin metabolism (HP:0100508) | 1.93200393 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.92839745 |
| 150 | Thrombophlebitis (HP:0004418) | 1.91967417 |
| 151 | Male pseudohermaphroditism (HP:0000037) | 1.91908222 |
| 152 | Neonatal onset (HP:0003623) | 1.91561410 |
| 153 | Fair hair (HP:0002286) | 1.91433032 |
| 154 | Attenuation of retinal blood vessels (HP:0007843) | 1.89324936 |
| 155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88977787 |
| 156 | Supernumerary spleens (HP:0009799) | 1.88229681 |
| 157 | Postaxial foot polydactyly (HP:0001830) | 1.87536625 |
| 158 | Axonal loss (HP:0003447) | 1.87454267 |
| 159 | Abnormality of iron homeostasis (HP:0011031) | 1.86837338 |
| 160 | Tubulointerstitial abnormality (HP:0001969) | 1.86171055 |
| 161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85691126 |
| 162 | Prolonged QT interval (HP:0001657) | 1.85436868 |
| 163 | Alkalosis (HP:0001948) | 1.85400268 |
| 164 | Vomiting (HP:0002013) | 1.84555867 |
| 165 | Gaze-evoked nystagmus (HP:0000640) | 1.83372004 |
| 166 | Ventricular tachycardia (HP:0004756) | 1.82729121 |
| 167 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82685250 |
| 168 | Pachygyria (HP:0001302) | 1.81422815 |
| 169 | Chorioretinal atrophy (HP:0000533) | 1.81130916 |
| 170 | Hyperkalemia (HP:0002153) | 1.80810365 |
| 171 | Retinal atrophy (HP:0001105) | 1.80403515 |
| 172 | Absent speech (HP:0001344) | 1.79787226 |
| 173 | Upper motor neuron abnormality (HP:0002127) | 1.79196681 |
| 174 | Hepatic necrosis (HP:0002605) | 1.78688799 |
| 175 | Large for gestational age (HP:0001520) | 1.78610474 |
| 176 | Abnormality of the gallbladder (HP:0005264) | 1.77132728 |
| 177 | Lipoatrophy (HP:0100578) | 1.76969299 |
| 178 | Hyporeflexia of lower limbs (HP:0002600) | 1.76700144 |
| 179 | Abnormality of urine glucose concentration (HP:0011016) | 1.76225930 |
| 180 | Glycosuria (HP:0003076) | 1.76225930 |
| 181 | Rickets (HP:0002748) | 1.75415117 |
| 182 | Enlarged kidneys (HP:0000105) | 1.75082673 |
| 183 | Decreased central vision (HP:0007663) | 1.74662769 |
| 184 | Severe muscular hypotonia (HP:0006829) | 1.74422869 |
| 185 | Ileus (HP:0002595) | 1.73284047 |
| 186 | Cerebral edema (HP:0002181) | 1.73239221 |
| 187 | Constricted visual fields (HP:0001133) | 1.72764643 |
| 188 | Dialeptic seizures (HP:0011146) | 1.72147094 |
| 189 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71632317 |
| 190 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71288050 |
| 191 | Lissencephaly (HP:0001339) | 1.70525620 |
| 192 | Elevated alkaline phosphatase (HP:0003155) | 1.70492981 |
| 193 | Pigmentary retinal degeneration (HP:0001146) | 1.70355224 |
| 194 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69732821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.98256929 |
| 2 | ERN1 | 3.87098805 |
| 3 | OBSCN | 3.58938013 |
| 4 | PDK2 | 3.57753470 |
| 5 | FGFR4 | 3.22373690 |
| 6 | FRK | 3.12765487 |
| 7 | SIK1 | 3.07508815 |
| 8 | MST1R | 2.94416655 |
| 9 | TAOK3 | 2.62590783 |
| 10 | TYK2 | 2.56745533 |
| 11 | MAP4K2 | 2.51112366 |
| 12 | TGFBR2 | 2.49870567 |
| 13 | NEK9 | 2.39315843 |
| 14 | CASK | 2.28704120 |
| 15 | INSRR | 2.22821471 |
| 16 | WNK3 | 2.16633370 |
| 17 | BMPR1B | 2.05960305 |
| 18 | PHKG2 | 1.91860238 |
| 19 | PHKG1 | 1.91860238 |
| 20 | IRAK3 | 1.89045490 |
| 21 | TBK1 | 1.88809221 |
| 22 | MAPK13 | 1.76947465 |
| 23 | ERBB4 | 1.75890445 |
| 24 | MAPK15 | 1.75639599 |
| 25 | PKN2 | 1.75205422 |
| 26 | MAP3K14 | 1.74948501 |
| 27 | BRSK2 | 1.73425827 |
| 28 | PNCK | 1.70488554 |
| 29 | STK38L | 1.70101331 |
| 30 | MARK1 | 1.68619011 |
| 31 | MAP3K4 | 1.62024663 |
| 32 | TIE1 | 1.57054864 |
| 33 | MAP3K10 | 1.56625564 |
| 34 | PTK6 | 1.55651262 |
| 35 | MAPK12 | 1.54417285 |
| 36 | MYLK | 1.51043923 |
| 37 | IRAK4 | 1.50088158 |
| 38 | GRK6 | 1.49000005 |
| 39 | PAK3 | 1.48853548 |
| 40 | MAPK11 | 1.48312831 |
| 41 | MAPK7 | 1.43369170 |
| 42 | CSF1R | 1.43222867 |
| 43 | JAK1 | 1.42934203 |
| 44 | OXSR1 | 1.40865029 |
| 45 | WNK4 | 1.36653262 |
| 46 | PIK3CG | 1.36282974 |
| 47 | BLK | 1.33337780 |
| 48 | JAK2 | 1.32432162 |
| 49 | TRIB3 | 1.31737582 |
| 50 | ACVR1B | 1.23947647 |
| 51 | PTK2B | 1.23635444 |
| 52 | FLT3 | 1.19552024 |
| 53 | ADRBK1 | 1.19297103 |
| 54 | NUAK1 | 1.15564842 |
| 55 | PRKCE | 1.13440473 |
| 56 | STK39 | 1.11710216 |
| 57 | TNIK | 1.09072501 |
| 58 | ERBB2 | 1.08283421 |
| 59 | MAPK4 | 1.07056581 |
| 60 | PRKAA2 | 1.06617156 |
| 61 | IKBKE | 1.06314094 |
| 62 | MAP2K4 | 1.04674494 |
| 63 | DYRK2 | 1.04229003 |
| 64 | FGFR2 | 1.02605904 |
| 65 | NTRK3 | 1.02116371 |
| 66 | GRK7 | 0.99760342 |
| 67 | CSK | 0.97059447 |
| 68 | CAMK1D | 0.96787476 |
| 69 | DAPK2 | 0.93505653 |
| 70 | CAMK2A | 0.93493890 |
| 71 | MAP4K1 | 0.93000172 |
| 72 | EPHB1 | 0.91477787 |
| 73 | CAMKK2 | 0.90776474 |
| 74 | MAP3K7 | 0.90462813 |
| 75 | TRPM7 | 0.87619663 |
| 76 | KIT | 0.87573864 |
| 77 | WEE1 | 0.86728277 |
| 78 | MAP2K7 | 0.85815472 |
| 79 | CDK6 | 0.85264990 |
| 80 | CAMK1 | 0.85067131 |
| 81 | LMTK2 | 0.84868019 |
| 82 | ABL2 | 0.84606813 |
| 83 | PDPK1 | 0.84064221 |
| 84 | PRKG2 | 0.83347726 |
| 85 | FGFR3 | 0.82359141 |
| 86 | MUSK | 0.82187767 |
| 87 | EPHA4 | 0.80464375 |
| 88 | MET | 0.79477901 |
| 89 | PRKCG | 0.78062178 |
| 90 | TTN | 0.75854933 |
| 91 | PDK1 | 0.74778967 |
| 92 | RIPK1 | 0.74694408 |
| 93 | IKBKB | 0.74604306 |
| 94 | IGF1R | 0.74417664 |
| 95 | NEK6 | 0.74164247 |
| 96 | MAP2K2 | 0.73184487 |
| 97 | PLK2 | 0.72326650 |
| 98 | LATS1 | 0.71598038 |
| 99 | PRKCZ | 0.71337178 |
| 100 | PRKACA | 0.69991785 |
| 101 | PKN1 | 0.69825804 |
| 102 | PINK1 | 0.67000146 |
| 103 | MAPKAPK3 | 0.65658233 |
| 104 | SGK3 | 0.65636944 |
| 105 | PRKACG | 0.64409351 |
| 106 | MKNK2 | 0.63601949 |
| 107 | STK11 | 0.60989971 |
| 108 | GRK5 | 0.59777602 |
| 109 | LYN | 0.59681821 |
| 110 | ZAP70 | 0.59367878 |
| 111 | ZAK | 0.59212868 |
| 112 | MAPKAPK5 | 0.58724220 |
| 113 | MATK | 0.58210037 |
| 114 | ITK | 0.58059395 |
| 115 | CAMK2D | 0.57990695 |
| 116 | PRKG1 | 0.57574547 |
| 117 | STK10 | 0.55974488 |
| 118 | CDK19 | 0.55462954 |
| 119 | ERBB3 | 0.55380832 |
| 120 | BTK | 0.54112158 |
| 121 | AKT3 | 0.53877349 |
| 122 | MAP3K3 | 0.52281030 |
| 123 | STK24 | 0.52231960 |
| 124 | KDR | 0.52141948 |
| 125 | MAP2K3 | 0.50876655 |
| 126 | STK38 | 0.50739386 |
| 127 | MAP3K2 | 0.49855283 |
| 128 | IRAK2 | 0.49662078 |
| 129 | GSK3A | 0.49245099 |
| 130 | PIK3CA | 0.48442569 |
| 131 | ROCK1 | 0.47542154 |
| 132 | NME1 | 0.47321810 |
| 133 | DYRK1B | 0.45195055 |
| 134 | HCK | 0.45064097 |
| 135 | TXK | 0.44927624 |
| 136 | BCR | 0.43749387 |
| 137 | PRKAA1 | 0.43682205 |
| 138 | EGFR | 0.43080921 |
| 139 | DMPK | 0.42960243 |
| 140 | PRKCQ | 0.42767329 |
| 141 | MAP2K6 | 0.41720216 |
| 142 | MAP3K5 | 0.41293618 |
| 143 | IRAK1 | 0.41235255 |
| 144 | GRK1 | 0.40690430 |
| 145 | CHUK | 0.40267233 |
| 146 | PTK2 | 0.39161718 |
| 147 | FER | 0.38242482 |
| 148 | NLK | 0.37870984 |
| 149 | SGK2 | 0.37171640 |
| 150 | CAMK4 | 0.36907369 |
| 151 | SYK | 0.36363464 |
| 152 | EPHA3 | 0.36346817 |
| 153 | MAP3K13 | 0.35953828 |
| 154 | PRKACB | 0.35860663 |
| 155 | PRKCA | 0.35192239 |
| 156 | DYRK1A | 0.34970578 |
| 157 | CSNK1A1 | 0.34263340 |
| 158 | CAMK2G | 0.34020852 |
| 159 | NTRK2 | 0.33440919 |
| 160 | PBK | 0.33052996 |
| 161 | ADRBK2 | 0.32972577 |
| 162 | BMX | 0.32484792 |
| 163 | TRIM28 | 0.31972683 |
| 164 | CDK5 | 0.31895200 |
| 165 | RET | 0.31306400 |
| 166 | CAMKK1 | 0.30490117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19408459 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68128111 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38789346 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96294476 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85391895 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76131584 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57014783 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44591842 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44530730 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41299982 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37356054 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35700345 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21423287 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18567932 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12576334 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09055374 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.98657205 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92620248 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91953560 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90241060 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89934392 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87154667 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.86055583 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81234037 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.79724858 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.75841574 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73629377 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67207179 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.65589863 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64333904 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64297973 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63669086 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62467786 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59342218 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.52210830 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50316691 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48813453 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44372175 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42832355 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41807597 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.38079942 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37255580 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32261362 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32207106 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31657618 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31298918 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30162688 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21683363 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19748428 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18483569 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18185329 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17513914 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13185802 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09061709 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08995120 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07471959 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04529223 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03450236 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01443419 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00736098 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00472659 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.99638227 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.99403250 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98406697 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94759323 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92790509 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90893714 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90658277 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88510697 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.88471626 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84296760 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82660153 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81967582 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81485844 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81282494 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78979667 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77495632 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77138632 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75641609 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.73124705 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72910409 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.72862498 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72636688 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70869737 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67113649 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67061079 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64905832 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60440304 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59879475 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58193296 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57058853 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.55296427 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54172343 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53121910 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.52993495 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51939313 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50374022 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49357407 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48197162 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47849943 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46040262 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45535637 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40854408 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39995228 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37837267 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37353128 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36456563 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36388757 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35686588 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34076380 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.33814899 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32404980 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32332903 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29203219 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26748211 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23432336 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.21612287 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20911226 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20758062 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.17339213 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14162633 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.11966114 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09444160 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07294243 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01445990 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.00088927 |
| 127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1157322 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1150037 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0924326 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0866583 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0769372 |
| 132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0726949 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | -0.0703016 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0681047 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0524440 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | -0.0456756 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0353557 |
| 138 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0209713 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0002052 |

